These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 27893707)

  • 21. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.
    Gao SP; Mark KG; Leslie K; Pao W; Motoi N; Gerald WL; Travis WD; Bornmann W; Veach D; Clarkson B; Bromberg JF
    J Clin Invest; 2007 Dec; 117(12):3846-56. PubMed ID: 18060032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The classic signalling and trans-signalling of interleukin-6 are both injurious in podocyte under high glucose exposure.
    Lei CT; Su H; Ye C; Tang H; Gao P; Wan C; He FF; Wang YM; Zhang C
    J Cell Mol Med; 2018 Jan; 22(1):251-260. PubMed ID: 28881473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17.
    Kennedy CL; Najdovska M; Jones GW; McLeod L; Hughes NR; Allison C; Ooi CH; Tan P; Ferrero RL; Jones SA; Dev A; Sievert W; Bhathal PS; Jenkins BJ
    J Pathol; 2011 Oct; 225(2):255-64. PubMed ID: 21710691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression.
    Jackson CB; Judd LM; Menheniott TR; Kronborg I; Dow C; Yeomans ND; Boussioutas A; Robb L; Giraud AS
    J Pathol; 2007 Oct; 213(2):140-51. PubMed ID: 17724739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.
    Hill DG; Yu L; Gao H; Balic JJ; West A; Oshima H; McLeod L; Oshima M; Gallimore A; D'Costa K; Bhathal PS; Sievert W; Ferrero RL; Jenkins BJ; Jones GW
    Int J Cancer; 2018 Jul; 143(1):167-178. PubMed ID: 29417587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
    Seto DN; Kandarian SC; Jackman RW
    J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway.
    Kuang Y; Guo W; Ling J; Xu D; Liao Y; Zhao H; Du X; Wang H; Xu M; Song H; Wang T; Jing B; Li K; Hu M; Wu W; Deng J; Wang Q
    Cell Death Dis; 2019 Apr; 10(4):297. PubMed ID: 30931929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema.
    Ruwanpura SM; McLeod L; Dousha LF; Seow HJ; Alhayyani S; Tate MD; Deswaerte V; Brooks GD; Bozinovski S; MacDonald M; Garbers C; King PT; Bardin PG; Vlahos R; Rose-John S; Anderson GP; Jenkins BJ
    Am J Respir Crit Care Med; 2016 Dec; 194(12):1494-1505. PubMed ID: 27373892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting.
    Zanders L; Kny M; Hahn A; Schmidt S; Wundersitz S; Todiras M; Lahmann I; Bandyopadhyay A; Wollersheim T; Kaderali L; Luft FC; Birchmeier C; Weber-Carstens S; Fielitz J
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):713-727. PubMed ID: 34821076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis.
    Jenkins BJ; Roberts AW; Greenhill CJ; Najdovska M; Lundgren-May T; Robb L; Grail D; Ernst M
    Blood; 2007 Mar; 109(6):2380-8. PubMed ID: 17082315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
    Mees ST; Toellner S; Marx K; Faendrich F; Kallen KJ; Schroeder J; Haier J; Kahlke V
    J Surg Res; 2009 Dec; 157(2):235-42. PubMed ID: 19589542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling three-dimensional cancer-associated cachexia and therapy: The molecular basis and therapeutic potential of interleukin-6 transignalling blockade.
    Cosentino M; Forcina L; Zouhair M; Apa L; Genovese D; Boccia C; Rizzuto E; Musarò A
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2550-2568. PubMed ID: 37727078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
    Tao L; Huang G; Wang R; Pan Y; He Z; Chu X; Song H; Chen L
    Sci Rep; 2016 Dec; 6():38408. PubMed ID: 27922075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.
    Mitsuyama K; Matsumoto S; Masuda J; Yamasakii H; Kuwaki K; Takedatsu H; Sata M
    Anticancer Res; 2007; 27(6A):3749-56. PubMed ID: 17970038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-6 mediated JAK/STAT3 signaling pathway in cancer patients with cachexia.
    Eskiler GG; Bezdegumeli E; Ozman Z; Ozkan AD; Bilir C; Kucukakca BN; Ince MN; Men AY; Aktas O; Horoz YE; Akpinar D; Genc I; Kaleli S
    Bratisl Lek Listy; 2019; 66(11):819-826. PubMed ID: 31747761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle.
    Pretto F; Ghilardi C; Moschetta M; Bassi A; Rovida A; Scarlato V; Talamini L; Fiordaliso F; Bisighini C; Damia G; Bani MR; Piccirillo R; Giavazzi R
    Oncotarget; 2015 Feb; 6(5):3043-54. PubMed ID: 25460504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells.
    Finotto S; Eigenbrod T; Karwot R; Boross I; Doganci A; Ito H; Nishimoto N; Yoshizaki K; Kishimoto T; Rose-John S; Galle PR; Neurath MF
    Int Immunol; 2007 Jun; 19(6):685-93. PubMed ID: 17496315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma.
    Cho HC; Lai CY; Shao LE; Yu J
    Cancer Res; 2011 Dec; 71(23):7250-8. PubMed ID: 22088965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling.
    Greenhill CJ; Gould J; Ernst M; Jarnicki A; Hertzog PJ; Mansell A; Jenkins BJ
    Immunol Cell Biol; 2012 May; 90(5):559-63. PubMed ID: 21670738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.
    Puppa MJ; Gao S; Narsale AA; Carson JA
    FASEB J; 2014 Feb; 28(2):998-1009. PubMed ID: 24145720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.